Formulation in Pharmacy Practice - eMixt

 This information is provided by Pharminfotech           Please read disclaimer before using this information          Back to Formulation Index Page
Overview: The solubility of labetalol hydrochloride in water is approximately 20mg per mL.  Solutions are most stable at pH 2 - 4.  
The stability of labetalol hydrochloride in distilled water, simple syrup, apple juice, grape juice and orange juice has been reported.1  Solutions were chemically stable in amber glass and plastic containers for 4 weeks.  Parabens can be added to these formulations to prevent microbial growth. The stabiity of labetalol has also been reported in Ora products (see below).

Alternatives to compounding: There are few specific indications for the use of labetalol, espcially in children; other beta-blockers may be available as licensed products or specials.The injection, 5mg per mL, could be administered orally if very small doses are required. Some tablet brands may disperse.

Formula 1

Labetalol 10mg per mL
Labetalol hydrochloride tablets 100mg 10 
Parabens 0.1  %
Suitable vehicle as above to 100  mL
If necessary adjust the final pH to about 4 with citric acid.
Expiry/Stability:    30 days.
Storage:  Refrigerate.  Protect from light (amber containers).
Shake well before use
(drug may be bound to insoluble tablet excipients).

  1. With the range of tablet strengths available, crushing or dispersing the tablet prior to adminstration is often possible.
  2. Labetalol 40mg per mL prepared from tablets in a 1:1 mixture of Ora-Sweet and Ora-Plus, or
    a 1:1 mixture of Ora-Sweet SF and Ora-Plus or Cherry Syrup was stable for up to 60 days
    at 5°C or 25°C, protected from light.2

  1. Nahata M.C.  Stability of labetalol hydrochloride in distrilled water, simple syrup and three fruit juices.
    DICP Ann Pharmacother 1991; 25: 465-9.
  2. Allen L.V., Erickson M.A.  Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
    Am J Health-Syst Pharm 1996; 53: 2304-9.

Formulation in Pharmacy Practice
Page Updated August 2011